Related Articles
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: Efficacy and safety in clinical practice
Clinical activity of regorafenib in elderly patients with recurrent glioblastoma
Value of α‑fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma
Effectiveness of the bevacizumab‑irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second‑line treatments without this regimen
Multimodal treatment for local recurrent malignant gliomas: Resurgery and/or reirradiation followed by chemotherapy